BIOTECanada’s Post

🔊 (sound on) Yesterday in Montreal, BIOTECanada brought together its members in Quebec, invited guests, and key stakeholders to Espace CDPQ for a lively panel discussion on enhancing Canada’s regulatory competitiveness and the attraction of investment into the biotechnology sector in Canada. Highlights included: * The pivotal role and intrinsic value of anchor companies within the expansive biotech ecosystem * Strategies for Canada to secure and retain biotech companies * Insights into the venture capital landscape and the broader investment climate * How organizations such as the Fonds de solidarité FTQ, as institutional investors, navigate the biotech innovation space, focusing on capital availability, investment opportunities, returns and the mandate on behalf of Quebecers * The crucial role of leveraging talent and mentorship opportunities to drive significant economic impact. A heartfelt thank you to our esteemed panelists: Mounia Azzi, PhD, Geneviève Guertin, Michael Mee, our host, Amplitude Ventures and to everyone who attended the event, your engagement fuels our collective path toward continued success in the biotech ecosystem. What was your most notable take-away from the event? If you missed the event, stay tuned for more opportunities to connect with us! Let’s keep the momentum going! #biotech #Canada #investment #innovation #policy #ecosystem #lifesciences #quebec adMare BioInnovations, J.P. Morgan, Ventus Therapeutics, Centre de production de produits biologiques (CPPB) inc. / Biologics Manufacturing Centre (BMC) Inc., Canadian Advanced Therapies Training Institute, KreaMedica Inc., Mintz, Epitopea, BIOQuebec, Domain Therapeutics, EVAH - Evolution for Animal Health, Health Innovation Capital, Molecular Forecaster, Merck, Thérapeutiques Thryv

𝗪𝗿𝗮𝗽𝗽𝗶𝗻𝗴 𝗨𝗽 𝗕𝗜𝗢-𝗘𝘂𝗿𝗼𝗽𝗲 𝗦𝗽𝗿𝗶𝗻𝗴 𝟮𝟬𝟮𝟰 𝗶𝗻 𝗕𝗮𝗿𝗰𝗲𝗹𝗼𝗻𝗮 💼    As we bid farewell to BIO-Europe Spring 2024, let's take a moment to reflect on the lively atmosphere and collaborative spirit that filled the event's halls.    ✨ Facts & Figures ✨    🤝 ~120,000 meeting requests  🤝 ~20,000 meetings  🏢 1,947 companies represented  👥 3,452 delegates attended  💌 MONIPOL prepared ~280 meeting requests and had 25 meetings    These numbers speak volumes about the energy and collaboration present at the event. We were fortunate to connect with many companies interested in exploring our services: throughout the event, we made it a priority to prepare thoroughly and understand our potential clients' needs. This emphasis on research and client-centricity beforehand ensured that meetings were not only productive but also truly beneficial for everyone involved 🤝    𝐇𝐚𝐯𝐞 𝐲𝐨𝐮 𝐦𝐢𝐬𝐬𝐞𝐝 𝐭𝐡𝐞 𝐜𝐡𝐚𝐧𝐜𝐞 𝐭𝐨 𝐜𝐨𝐧𝐧𝐞𝐜𝐭 𝐰𝐢𝐭𝐡 𝐮𝐬 𝐚𝐭 𝐭𝐡𝐞 𝐞𝐯𝐞𝐧𝐭? Don't worry! Contact us for follow-ups and learn more about how we can support your trials. Let's continue the conversation and explore exciting opportunities at the Virtual Partnering Event, held on 26-27 March 📅     A big thank you to everyone who made BIO-Europe Spring 2024 such a success. We are looking forward to connecting further and supporting innovative biotech pioneers.    Another big thanks to EBD Group for providing a platform to connect the global BioPharma community. We are pleased to have played a part in fostering this vibrant atmosphere.      #BIOEuropeSpring #Biotech #CRO #clinicaltrials #clinicaldevelopment 

Do look out for Helen Chen, Shriharsha Sarkar and I at #AsiaBioPartneringForum this week, and listen out for the latest on the Asia’s #biopharma developments and opportunities

Looking forward to connecting with Bio Companies at Bio Europe Spring to Dive into the compelling reasons why Puerto Rico stands out as a prime destination for Bio Pharma companies growth: - Puerto Rico Talent: Tap into a skilled and diverse workforce, fostering innovation and driving success. - Tax benefits: 1-4% fixed corporate tax rate on eligible income, among other financial incentives. - Part of the U.S.: Puerto Rico offers the same level of operational security, political stability and support, and protections available on the mainland.  - R&D Tax Credit: Up to 50% Tax Credit on qualified Research & Development Activities - Transferable & Sellable. - Innovation: Seamless integration into a thriving tech innovation R&D ecosystem. Last but not least ! Puerto Rico is “The Gateway to the Americas.” From here, you can access the North American, South American, and Caribbean markets with ease and stability under the Made in the USA seal See you soon Bio Europe !!!! #bioeuropespring #Bioconvention #Europe

Calluna Pharma is attending Bio€quity Europe conference, taking place 12-14 May, organized by BioCentury Inc. and EBD Group. Our CEO John Montana is going to be in San Sebastian next week for one of Europe’s top experiences for CEOS and investors to network, partner and discuss key issues facing the biotech industry. This is an opportunity to learn more about how to reach discussion stage with investors, discover 100+ emerging biotechs, and dive into European biotech trends. Find out more, and join us here: https://lnkd.in/dzunkQc #Biotech #Pharma #VentureCapital #BioEquityEurope #BioEquity

📆 There’s just 4 days left to apply to present you company at BIO-Europe this November, 4–6, in Stockholm. 🇸🇪 🚀 Check out the benefits of presenting: • INCREASED VISIBILITY. Raise your company's profile and generate interest among top-tiers investors, biopharma execs and potential partners attending BIO-Europe. • PRE-RECORD YOUR PITCH. All BIO-Europe presenters will have the opportunity to pre-record their pitch to be watched on demand for all registered attendees up to 3 weeks before the event. • MORE MEETINGS. Your presentation in partneringONE® will include a link for attendees to schedule one-to-one meetings with your company. Statistics from previous events show that presenting companies receive up to 20% more meeting requests. Apply to present before September 12th >> http://spr.ly/6042YqnyG #BIOEurope #EBDGroup #Present #Innovation #Stockholm #Sweden

🌟 Attention Swiss Biotech Companies and Clusters! 🌟 Are you ready to immerse yourself in the dynamic world of Asian biotech? Join the Swiss Pavilion at BioJapan for a golden opportunity to connect, collaborate, and catalyze innovation within the heart of the Asian biotech community. 🔬 Why Join? A powerhouse of universities, cutting-edge biotechs, and leading Japanese & global pharmaceutical giants convene each year at BioJapan. This event is not just a trade show; its partnering program offers opportunities for collaborations in Biotechnology, Regenerative Medicine, and the Healthcare industry. Last year alone witnessed over 9,000 business discussions, shaping the future of the industry! 📋 Check Out the 2023 Participant List: https://lnkd.in/g8xPX5t4.. 📅 Registration Deadline: April 30, 2024 Secure your spot now and unlock unparalleled networking opportunities, collaborative ventures, and visibility on the global stage. Let's shape the future of biotech together! For more information and registration, check out the following site that includes a fact sheet about the biotech industry in Japan. Sign up if you want to grow in the Asian biotech market! 🌐 https://lnkd.in/gg_d_TQu.. #SwissPavilion #BioJapan #Biotech #RegenerativeMedicine #HealthcareIndustry #NetworkingOpportunity #pharma 🚀

Unlock the secrets to successful partnerships in the biotech sector! 🎙️ In this episode of BIO from the BAYOU, we sit down with Tari Suprapto, PhD, Director of Search and Evaluation at Novo Nordisk, who shares her strategies for fostering strong academic-corporate relationships – tips that also work for many smaller companies talking to larger ones. Learn how to navigate the challenges of communication, align goals, and overcome imposter syndrome in high-stakes environments. 🚀 Listen now to gain actionable insights on building and maintaining impactful partnerships in biotech! 🔗 Link in comments ➡️ #Biotech #Partnerships #Innovation #AcademicResearch #CorporateCollaboration #ImposterSyndrome #NovoNordisk

Just Announced: BioCentury Inc. and The BayHelix Group will bring the 4th East-West Biopharma Summit back to Singapore in March 2025. Why #Singapore?     ➤ Government support: After 20 years of government-led investment in science, talent, and infrastructure, the stage is set for the #lifesciences industry to carry the ball forward. ➤ Top investors: With #VC money pouring in, new investment and partnerships opportunities are emerging. ➤ Asia hub: As the gateway to Asia, Singapore is the place to meet industry leaders from an emerging Arc of Innovation including Japan, Korea, China, Australia, India, and Southeast Asia.    Please join us for this exclusive event designed for VCs and #biopharma decision-makers. Register for #BioCenturyEastWest with early bird rates: https://loom.ly/WqidFHU

ARVOR has been at the forefront of Spanish biotech sector for over 20 years. We specialize in transforming research into reality, guiding you through the intricate landscape of the Spanish market. Here's how we empower your success: - Expert evaluation: We meticulously assess your biotech innovation's commercial potential and market fit within Spain. - Strategic partnering: With our extensive network, we connect you with the ideal investors, industry leaders, and resources to accelerate your progress. - Spanish market navigation: Don't navigate the complexities alone. We'll be your guide, ensuring a smooth and efficient path to market entry. We understand the regulatory issues, market dynamics, and key players in Spain's biotech scene. In addition to evaluation and partnering, ARVOR brings extensive expertise in market analysis, business plan development, partner scouting, and implementation strategies. Book a meeting with us today: https://lnkd.in/dW-sBcJE ➡️ Are you aiming to stablish a robust biotech business in Spain? Let's discuss how ARVOR can turn your vision into reality. #biotech #spain #innovation #partnerships #marketentry #success